Glucocorticoid regulation of receptor activator of NF-κB (RANK), osteoprotegerin (OPG) and RANK ligand (RANKL) in mouse calvarial bone.

被引：0
|
作者：
Swanson, C
Lorentzon, M
Conaway, H
Lerner, UH
机构：
[1] Univ Gothenburg, Dept Internal Med, Ctr Bone Res, Sahlgrenska Acad CBI, Gothenburg, Sweden
[2] Univ Arkansas Med Sci, Dept Physiol & Biophys, Little Rock, AR 72205 USA
[3] Umea Univ, Dept Oral Cell Biol, Umea, Sweden
来源：
JOURNAL OF BONE AND MINERAL RESEARCH | 2004年 / 19卷
关键词：
D O I：
暂无
中图分类号：
R5 [内科学];
学科分类号：
1002 ; 100201 ;
摘要：
引用
收藏
页码：S200 / S200
页数：1
相关论文
共 50 条
  • [1] Expression Profile of Receptor Activator of Nuclear-κB (RANK), RANK Ligand (RANKL) and Osteoprotegerin (OPG) in Breast Cancer
    Owen, Sioned
    Ye, Lin
    Sanders, Andrew J.
    Mason, Malcolm D.
    Jiang, Wen G.
    [J]. ANTICANCER RESEARCH, 2013, 33 (01) : 199 - 206
  • [2] Glucocorticoid regulation of osteoclast differentiation and expression of receptor activator of nuclear factor-κB (NF-κB) ligand, osteoprotegerin, and receptor activator of NF-κB in mouse calvarial bones
    Swanson, Charlotte
    Lorentzon, Mattias
    Conaway, H. Herschel
    Lerner, Ulf H.
    [J]. ENDOCRINOLOGY, 2006, 147 (07) : 3613 - 3622
  • [3] Receptor Activator of Nuclear Transcription Factor NF-κB (RANK), Its Ligand RANKL, and Natural Inhibitor of RANKL Osteoprotegerin (OPG) in the Blood Serum of Patients with Primary Bone Tumors
    N. E. Kushlinskii
    E. S. Gershtein
    Yu. N. Solov’ev
    Yu. S. Timofeev
    I. V. Babkina
    A. O. Dolinkin
    A. A. Zuev
    O. I. Kostyleva
    [J]. Bulletin of Experimental Biology and Medicine, 2017, 163 : 478 - 481
  • [4] Receptor Activator of Nuclear Transcription Factor NF-κB (RANK), Its Ligand RANKL, and Natural Inhibitor of RANKL Osteoprotegerin (OPG) in the Blood Serum of Patients with Primary Bone Tumors
    Kushlinskii, N. E.
    Gershtein, E. S.
    Solov'ev, Yu. N.
    Timofeev, Yu. S.
    Babkina, I. V.
    Dolinkin, A. O.
    Zuev, A. A.
    Kostyleva, O. I.
    [J]. BULLETIN OF EXPERIMENTAL BIOLOGY AND MEDICINE, 2017, 163 (04) : 478 - 481
  • [5] Berberine alleviates oxidative stress in rats with osteoporosis through receptor activator of NF-κB/receptor activator of NF-κBligand/osteoprotegerin (RANK/RANKL/OPG) pathway
    He, Xiao-Feng
    Zhang, Long
    Zhang, Chun-Hua
    Zhao, Con-Ran
    Li, Heng
    Zhang, Ling-Fei
    Tian, Guo-Feng
    Guo, Ming-Feng
    Dai, Zheng
    Sui, Fu-Ge
    [J]. BOSNIAN JOURNAL OF BASIC MEDICAL SCIENCES, 2017, 17 (04) : 295 - 301
  • [6] The functions of the avian receptor activator of NF-κB ligand (RANKL) and its receptors, RANK and osteoprotegerin, are evolutionarily conserved
    Sutton, Kate M. C.
    Hu, Tuanjun
    Wu, Zhiguang
    Siklodi, Botond
    Vervelde, Lonneke
    Kaiser, Pete
    [J]. DEVELOPMENTAL AND COMPARATIVE IMMUNOLOGY, 2015, 51 (01): : 170 - 184
  • [7] TNF-family member Receptor Activator of NF-κB (RANK) and RANK-Ligand (RANKL) in bone remodelling
    Quax, W. J.
    van Assen, A. H. G.
    Wang, Y. Z.
    [J]. 4TH INTERNATIONAL CONFERENCE ON AGRICULTURAL AND BIOLOGICAL SCIENCES, 2018, 185
  • [8] Pathophysiology of RANK ligand (RANKL) and osteoprotegerin (OPG)
    Hofbauer, L. C.
    [J]. ANNALES D ENDOCRINOLOGIE, 2006, 67 (02) : 139 - 141
  • [9] Receptor activator NF κB ligand (RANKL) and osteoprotegerin (OPG) protein expression in periodontitis
    Crotti, T
    Smith, MD
    Hirsch, R
    Soukoulis, S
    Weedon, H
    Capone, M
    Ahern, MJ
    Haynes, D
    [J]. JOURNAL OF PERIODONTAL RESEARCH, 2003, 38 (04) : 380 - 387
  • [10] Expression of bone-regulating factors osteoprotegerin (OPG) and receptor activator of NF-κB ligand (RANKL) in heterotopic vascular ossification
    Al-Fakhri, N
    Hofbauer, LC
    Preissner, KT
    Franke, FE
    Schoppet, M
    [J]. THROMBOSIS AND HAEMOSTASIS, 2005, 94 (06) : 1335 - 1337
12345